Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives $614.95 Average Target Price from Analysts

Intuitive Surgical, Inc. (NASDAQ:ISRG) has earned a consensus rating of “Moderate Buy” from the twenty-five ratings firms that are presently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, sixteen have issued a buy recommendation and two have given a strong buy recommendation to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $614.9545.

Several brokerages have recently issued reports on ISRG. Wells Fargo & Company increased their price objective on shares of Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a research report on Friday, December 12th. Zacks Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 19th. TD Cowen upgraded Intuitive Surgical to a “strong-buy” rating in a report on Tuesday, January 27th. Royal Bank Of Canada lifted their target price on Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a research report on Wednesday, December 17th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Monday, December 29th.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $452.77 on Friday. The stock has a 50 day simple moving average of $492.86 and a 200 day simple moving average of $513.66. Intuitive Surgical has a 52-week low of $425.00 and a 52-week high of $603.88. The firm has a market capitalization of $160.79 billion, a PE ratio of 57.39, a P/E/G ratio of 3.49 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping the consensus estimate of $2.27 by $0.26. The firm had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business’s quarterly revenue was up 18.8% on a year-over-year basis. During the same period last year, the company posted $2.21 EPS. Equities research analysts predict that Intuitive Surgical will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In related news, SVP Mark Brosius sold 645 shares of the stock in a transaction on Monday, March 9th. The shares were sold at an average price of $485.01, for a total transaction of $312,831.45. Following the completion of the transaction, the senior vice president owned 1,613 shares in the company, valued at approximately $782,321.13. This represents a 28.57% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP Fredrik Widman sold 133 shares of Intuitive Surgical stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $65,829.68. Following the completion of the sale, the vice president owned 660 shares in the company, valued at $326,673.60. The trade was a 16.77% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 32,943 shares of company stock valued at $17,279,568 over the last ninety days. 0.60% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Intuitive Surgical

A number of large investors have recently modified their holdings of the business. Norges Bank bought a new stake in Intuitive Surgical during the fourth quarter worth about $2,856,987,000. J. Stern & Co. LLP grew its stake in Intuitive Surgical by 18,504.6% in the fourth quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider’s stock valued at $1,204,788,000 after purchasing an additional 2,115,814 shares in the last quarter. Northwestern Mutual Wealth Management Co. increased its position in shares of Intuitive Surgical by 1,043.3% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 1,342,121 shares of the medical equipment provider’s stock worth $760,124,000 after purchasing an additional 1,224,734 shares during the last quarter. Rakuten Investment Management Inc. acquired a new position in shares of Intuitive Surgical during the 3rd quarter worth approximately $388,436,000. Finally, Polen Capital Management LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $477,225,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.